Human T lymphotropic virus type 1 (HTLV-1) is endemic in the southern part of Japan. Infection of the virus can cause adult T cell leukemia/lymphoma (ATL), while most infected individuals remain in a carrier state for a long period of time. Although rare cases of carriers, like ATL patients, who developed opportunistic infections, have been reported, hematological changes of carriers who are prone to opportunistic infections have not been well defined. Here, we present a case of an HTLV-1 carrier who developed Mycobacterium intracellulare infection and Pneumocystis jirovecii pneumonia (PcP) simultaneously.
Introduction

HITV-1 is an endemic retrovirus and infects CD4
+ T cells. A part of HTLV-1-infected patients develop ATL, who often suffer from opportunistic infections due to cellular immunodeficiency. Most infected patients remain asymptomatic
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Case Report
A 68-year-old woman, who had previously been in a healthy state, developed a productive cough that lasted for approximately 2 months and was referred to (Table 2) . We administered trimethoprim- follow-up chest CT findings showed no consolidation or ground-glass nodules (Figure 1(c) ). At the time of writing, the patient is receiving medication for NTM infection as well as trimethoprim-sulfamethoxazole as a prophylactic.
Discussion
HTLV-1 is a retrovirus and endemic in southern part of Japan. While most infected patients remain asymptomatic carriers, approximately 5% of infected patients develop ATL and suffer from opportunistic infections because of cellular immunodeficiency [1] . Although there are some reports suggesting that HTLV-1 carriers are also prone to bacterial or fungal infections [2] [3] [4] [5] , their immunological states have not been elucidated compared with that of ATL patients. In this report, we presented an HTLV-1 carrier who developed NTM infection and PcP simultaneously, and showed cellular compositional changes similar to ATL patients in her bone marrow. Diagnosis of HTLV-1 carrier state and ATL are based on Shimoyama criteria [6] . This defines that the detection of abnormal lymphocytes in peripheral blood or organs such as lymph nodes is required for the diagnosis of ATL. Based on this, the patient was diagnosed with a carrier state when she developed PcP because of no apparent abnormal lymphocytes in her blood and bone marrow samples. The previous study reported that HTLV-1 carriers suffered from various kinds of opportunistic infections including PcP, cryptococcal meningitis and strongyloidiasis and, moreover, many of them progressed ATL in a few years following those infectious diseases [9] . In patients with opportunistic infections of unknown origin, an HTLV-1 infection should be considered as a cause of immunodeficiency in HTLV-1 endemic areas.
In the present case, acute respiratory failure progressed during treatment of an NTM infection. Another medical interview and bronchoscopy helped us diagnose HTLV-1 infection and PcP. Because HTLV-1-infected patients exhibit various types of abnormalities in chest CT [10] , bronchoscopy is of importance to differentiate pulmonary infections from HTLV-1-derived lung disease. In addition, the possibilities of multiple pathogen infections, like the present case, should be always kept in mind. The present patient is now treated with watchful waiting as smoldering ATL, however the long-term prognosis of smoldering ATL was reported to be poor [11] . She may progress acute ATL and opportunistic infections in the future and therefore should be carefully observed in clinical practice.
Conclusion
In conclusion, we reported an HTLV carrier who developed NTM infection and PcP simultaneously. We also indicated the possibilities of cellular compositional changes in her bone marrow in the basis of the development of this opportunistic infection. Further evaluation is warranted to assess clinical implications of this immunological abnormality in HTLV-1 carriers.
Consent
Informed consent was obtained from the patient to report this case.
